Terms: = Pancreatic cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
56 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of the RAF/MEK/ERK Signaling Cascade in pancreatic cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
3. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
4. src is a target molecule of mannose against pancreatic cancer cells growth in vitro & in vivo.
Xie J; Wu S; Liao W; Ning J; Ding K
Glycobiology; 2023 Oct; 33(10):766-783. PubMed ID: 37658770
[TBL] [Abstract] [Full Text] [Related]
5. Clinical and Genomic Characterization of pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
[TBL] [Abstract] [Full Text] [Related]
6. Functional roles of src signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.
Poh AR; Ernst M
Oncogene; 2023 Jun; 42(22):1786-1801. PubMed ID: 37120696
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in pancreatic Ductal Adenocarcinoma Microenvironment.
Yin Z; Chen S
Pancreas; 2022 Oct; 51(9):1235-1247. PubMed ID: 37078951
[TBL] [Abstract] [Full Text] [Related]
8. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
[TBL] [Abstract] [Full Text] [Related]
9. Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for pancreatic cancer.
Chen H; Zhou W; Bian A; Zhang Q; Miao Y; Yin X; Ye J; Xu S; Ti C; Sun Z; Zheng J; Chen Y; Liu M; Yi Z
Clin Cancer Res; 2023 Feb; 29(4):815-830. PubMed ID: 36374556
[TBL] [Abstract] [Full Text] [Related]
10. SNAP23-Mediated Perturbation of Cholesterol-Enriched Membrane Microdomain Promotes Extracellular Vesicle Production in src-Activated cancer Cells.
Mitani F; Hayasaka R; Hirayama A; Oneyama C
Biol Pharm Bull; 2022; 45(10):1572-1580. PubMed ID: 36184518
[TBL] [Abstract] [Full Text] [Related]
11. Identification of a novel Calpain-2-src feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma.
Ma XL; Zhu KY; Chen YD; Tang WG; Xie SH; Zheng H; Tong Y; Wang YC; Ren N; Guo L; Lu RQ
Oncogene; 2022 Jul; 41(27):3554-3569. PubMed ID: 35697802
[TBL] [Abstract] [Full Text] [Related]
12. TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through src/FAK/p-Akt/IL-1β signaling.
Wu J; Wang Y; Yang Y; Liu F; Jiang Z; Jiang Z
Int Immunopharmacol; 2022 Jan; 102():108429. PubMed ID: 34906856
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9.
Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C
Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382
[TBL] [Abstract] [Full Text] [Related]
14. MUC Glycoproteins: Potential Biomarkers and Molecular Targets for cancer Therapy.
Ratan C; Cicily K D D; Nair B; Nath LR
Curr Cancer Drug Targets; 2021; 21(2):132-152. PubMed ID: 33200711
[TBL] [Abstract] [Full Text] [Related]
15. Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis.
Jiang K; Dong C; Yin Z; Li R; Mao J; Wang C; Zhang J; Gao Z; Liang R; Wang Q; Wang L
Cell Death Dis; 2020 Nov; 11(11):972. PubMed ID: 33184263
[TBL] [Abstract] [Full Text] [Related]
16. Silencing Delta-like 1 Expression Induces Migratory Features in pancreatic cancer Cells Through Stimulation of src and p38 Signalling Pathway.
Lee J; Lee J; Kim DH; Kim JH
Anticancer Res; 2020 Mar; 40(3):1335-1344. PubMed ID: 32132030
[TBL] [Abstract] [Full Text] [Related]
17. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of src signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract] [Full Text] [Related]
18. Targeting the complexity of src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.
Parkin A; Man J; Timpson P; Pajic M
FEBS J; 2019 Sep; 286(18):3510-3539. PubMed ID: 31330086
[TBL] [Abstract] [Full Text] [Related]
19. Identification of downstream target genes regulated by CX43 in hepatocellular carcinoma.
Wang ZS; Tan Z; Wu ZH; Zhan SX; Guo WD; Liu SG; Zhang L
Neoplasma; 2019 Nov; 66(6):870-878. PubMed ID: 31307202
[TBL] [Abstract] [Full Text] [Related]
20. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis.
Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
Neoplasma; 2019 Sep; 66(5):681-693. PubMed ID: 31169017
[TBL] [Abstract] [Full Text] [Related]
[Next]
